Kenvue (NYSE:KVUE) (NYSE: KVUE) is a consumer health company that develops, markets and sells self-care, skin health and essential health products. Its portfolio includes over-the-counter medicines, allergy and cold remedies, pain-relief products, oral-care items, wound-care products, baby care products and beauty brands.
Kenvue’s principal brands include Tylenol, Motrin, Zyrtec, Benadryl, Neutrogena, Aveeno, Listerine, Johnson’s and BAND-AID. The company distributes its products through pharmacies, retailers, e-commerce channels, healthcare providers and other commercial outlets in markets around the world.
Kenvue was formed through the separation of Johnson & Johnson’s consumer health business and became an independent publicly traded company in 2023. The company is headquartered in Skillman, New Jersey, and serves consumers across a broad range of geographic markets. Its leadership is focused on expanding its established brand portfolio and developing consumer health products intended for everyday use.
